Cargando…
IKBKE regulates cell proliferation and epithelial–mesenchymal transition of human malignant glioma via the Hippo pathway
IKBKE is increased in several types of cancers and is associated with tumour malignancy. In this study, we confirmed that IKBKE promoted glioma proliferation, migration and invasion in vitro. Then, we further discovered that IKBKE increased Yes-associated protein 1 (YAP1) and TEA domain family membe...
Autores principales: | Lu, Jie, Yang, Yi, Guo, Gaochao, Liu, Yang, Zhang, Zhimeng, Dong, Shicai, Nan, Yang, Zhao, Zhenyi, Zhong, Yue, Huang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564784/ https://www.ncbi.nlm.nih.gov/pubmed/28548934 http://dx.doi.org/10.18632/oncotarget.17738 |
Ejemplares similares
-
Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
por: Liu, Yang, et al.
Publicado: (2017) -
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
por: Wang, Xin, et al.
Publicado: (2021) -
IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway
por: Bainbridge, Alex, et al.
Publicado: (2020) -
IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3/PD‐L1 pathway
por: Yi, Li, et al.
Publicado: (2020) -
Amlexanox Enhances Temozolomide-Induced Antitumor
Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR
Signaling Pathway
por: Xiong, Jinbiao, et al.
Publicado: (2021)